MedPath

Pan-European IDEFICS/I.Family children cohort

Not Applicable
Completed
Conditions
utrition and lifestyle-related disorders with a particular focus on overweight/obesity
Nutritional, Metabolic, Endocrine
Nutrition and lifestyle-related disorders with a particular focus on overweight/obesity
Registration Number
ISRCTN62310987
Lead Sponsor
eibniz Institute for Prevention Research and Epidemiology - BIPS
Brief Summary

2017 Results article in https://www.ncbi.nlm.nih.gov/pubmed/28040744 results 2019 Results article in https://www.ncbi.nlm.nih.gov/pubmed/30651891 results 2019 Results article in https://www.ncbi.nlm.nih.gov/pubmed/31302103 results (added 16/07/2019) 2018 Results article in https://www.ncbi.nlm.nih.gov/pubmed/30139409 results (added 08/10/2019) 2020 Results article in https://pubmed.ncbi.nlm.nih.gov/33009293/ results (added 07/10/2020) 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/33352571/ results (added 23/12/2020) 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/34243726/ (added 12/07/2021) 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/34663352/ Media use trajectories and risk of metabolic syndrome (added 21/10/2021) 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/34732214/ (added 05/11/2021) 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/36494689/ (added 12/12/2022) 2018 Protocol article in https://doi.org/10.1007/978-3-319-98857-3_5 (added 23/11/2023) 2023 Results article in https://pubmed.ncbi.nlm.nih.gov/38048991/ (added 05/12/2023)

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
16229
Inclusion Criteria

1. At the baseline survey (T0) all children, boys and girls, 2 - 9.9 years of age, attending the participating kindergartens and schools of the selected intervention and control areas in the 8 survey countries were eligible as participants. These criteria were extended to the Polish survey in 2014.
2. At the second wave of examinations (T1) all children who participated in T0 plus their classmates were invited to participate.
3. At the third wave (T3) all children who had participated either at T0 or T1 (index children) were re-invited together with their siblings in the age range 2-15 years, and both their parents.
4. Study subjects had to be residents of the selected control or intervention regions at T0.
5. Participant inclusion required that parents gave written informed consent for their children and in T3 also for themselves. Additionally, children from the age of 12 years onwards also had to give written informed consent.

Exclusion Criteria

1. Children outside the defined age rage
2. Children not living in the study regions at T0

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath